Efficacy and safety of simeprevir and sofosbuvir with and without ribavirin in subjects with recurrent genotype 1 hepatitis C postorthotopic liver transplant: the randomized GALAXY study.
about
Filling the gap between clinical trials and real life in the treatment of severe HCV recurrence after liver transplantation.Real-world cure rates for hepatitis C virus treatments that include simeprevir and/or sofosbuvir are comparable to clinical trial results.Clinical impact of pharmacokinetic interactions between the HCV protease inhibitor Simeprevir and frequently used concomitant medications.
P2860
Efficacy and safety of simeprevir and sofosbuvir with and without ribavirin in subjects with recurrent genotype 1 hepatitis C postorthotopic liver transplant: the randomized GALAXY study.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Efficacy and safety of simepre ...... : the randomized GALAXY study.
@en
type
label
Efficacy and safety of simepre ...... : the randomized GALAXY study.
@en
prefLabel
Efficacy and safety of simepre ...... : the randomized GALAXY study.
@en
P2093
P2860
P356
P1476
Efficacy and safety of simepre ...... : the randomized GALAXY study.
@en
P2093
Adam Shprecher
Andrew Muir
Avinash Prabhakar
Christopher O'Brien
Jacqueline G O'Leary
James R Burton
Kimberly Brown
Mordechai Rabinovitz
Rajender Reddy
Robert J Fontana
P2860
P304
P356
10.1111/TRI.12896
P577
2016-11-29T00:00:00Z